CONMED EVP Unloads $641,034 in Stock (CNMD)
CONMED (NASDAQ:CNMD) EVP William Abraham sold 16,062 shares of the stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $39.91, for a total transaction of $641,034.42. Following the transaction, the executive vice president now directly owns 1,486 shares of the company’s stock, valued at approximately $59,306. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
CNMD has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of CONMED in a research note on Wednesday. They now have a $42.00 price target on the stock.
CONMED (NASDAQ:CNMD) traded up 1.28% during mid-day trading on Thursday, hitting $40.40. The stock had a trading volume of 336,216 shares. CONMED has a one year low of $32.21 and a one year high of $50.47. The stock has a 50-day moving average of $38.86 and a 200-day moving average of $43.72. The company has a market cap of $1.105 billion and a price-to-earnings ratio of 31.94.
CONMED (NASDAQ:CNMD) last released its earnings data on Wednesday, July 23rd. The company reported $0.47 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.47. The company had revenue of $188.20 million for the quarter, compared to the consensus estimate of $190.62 million. During the same quarter in the previous year, the company posted $0.43 earnings per share. The company’s revenue for the quarter was down 2.5% on a year-over-year basis. Analysts expect that CONMED will post $1.87 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Monday, October 6th. Stockholders of record on Monday, September 15th will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.01%. The ex-dividend date of this dividend is Thursday, September 11th.
CONMED Corporation (NASDAQ:CNMD) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.